Skip to main content
Equibles

Stratos Wealth Partners, LTD.

Position in GALT — Galectin Therapeutics Inc

CIK 1612865 BEACHWOOD, OH
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$88,568
+$33,081 QoQ
Shares Held
19,088
-4.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Stratos Wealth Partners, LTD. holds $14,445,280 across 20 Biotechnology names. GALT ranks #18 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZVRA
Zevra Therapeutics, Inc.
 408,000 $5,850,720
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,267 $1,622,816
3 PLX
Protalix BioTherapeutics, Inc.
 500,000 $1,165,000
4 PHAT
Phathom Pharmaceuticals, Inc.
 100,000 $1,085,000
5 IONS
Ionis Pharmaceuticals Inc
 7,801 $618,541
6 KRYS
Krystal Biotech, Inc.
 1,382 $513,647
7 BBIO
BridgeBio Pharma, Inc.
 6,603 $491,791
8 GANX
Gain Therapeutics, Inc.
 200,000 $406,000

All Filings in GALT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $88,568 19,088
2026-03-31 $55,487 19,888
2025-12-31 $79,406 19,088
2025-09-30 $127,412 30,050
2025-06-30 $128,182 60,750
2025-03-31 $62,891 51,550
2024-12-31 $66,499 51,550
2024-09-30 $111,237 40,450
2024-06-30 $91,417 40,450
2024-03-31 $96,675 40,450
2023-12-31 $67,147 40,450
2023-09-30 $77,664 40,450
2023-06-30 $58,248 40,450
2023-03-31 $84,945 40,450
2022-12-31 $46,273 40,950
2022-09-30 $66,748 40,950
2022-06-30 $53,644 40,950
2022-03-31 $65,929 40,950
2021-12-31 $84,766 40,950
2021-09-30 $158,886 40,950
2021-06-30 $131,040 40,950
2021-03-31 $88,861 40,950
2020-12-31 $91,728 40,950
2020-09-30 $110,671 41,450
2020-06-30 $126,837 41,450
2020-03-31 $81,242 41,450